drugset / Trial / NCT02231931

Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

NCT02231931

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the mutual interaction potential of digoxin, furosemide, metformin, and rosuvastatin when given alone or together as a cocktail, and to investigate the effect of high doses of metformin or furosemide on pharmacokinetics of the other cocktail compounds

Timeline

Start
2014-09-01
Primary completion
2015-01-01
Completion
2015-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified Oral
Subject Furosemide Other / unclassified 0.5 ml Oral
Subject Furosemide Other / unclassified 2 ml Oral
Subject Metformin Small molecule Oral
Subject Rosuvastatin Small molecule Oral

Indications

No indication recorded.